Introduction According to the literature, the annual deaths caused by cardiovascular
diseases are dramatically increasing. 1, 2 In addition to the human costs, in the UK alone …

A comprehensive, biophysically accurate, computational model of vascular endothelial
growth factor (VEGF) family member interactions with endothelial cell surface receptors was …

Vascular endothelial growth factor (VEGF) is a strong promoter of angiogenesis in tumors,
and anti‐VEGF treatment, such as a humanized antibody to VEGF, is clinically used as a …

Please cite this paper as: Fedosov, Caswell, Popel and Karniadakis (2010). Blood Flow and
Cell‐Free Layer in Microvessels. Microcirculation17 (8), 615–628. Abstract Blood is …

Angiogenesis, the process of new blood vessel formation from preexisting ones, plays a
pivotal role in tumor growth. Vascular endothelial growth factor receptor‐2 (VEGFR2) is the …

Tumour angiogenesis allows a growing mass of cancer cells to overcome oxygen diffusion
limitation and to increase cell survival. The growth of capillaries from pre-existing blood …

As illustrated in detail in chapters 1 and 2, the arterial wall is a heterogeneous structure
consisting of several layers which strongly differ in their thickness and in their biological and …

EDITORIAL published: 13 September 2013 doi: 10.3389/fonc. 2013.00233 stem cells in
endometrial cancer. Jain and Jackson ( 4) present a hybrid model that simulates the …

Vascular endothelial growth factor (VEGF) has been known as a key mediator of
angiogenesis in cancer. Bevacizumab is anti-VEGF monoclonal antibody that has been …

Tumor associated angiogenesis is the development of new blood vessels in response to
proteins secreted by tumor cells. These new blood vessels allow tumors to continue to grow …